Related Experiment Video

Updated: Jul 9, 2026

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
07:25

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

Viral elimination reduces incidence of malignant lymphoma in patients with hepatitis C

Yusuke Kawamura1, Kenji Ikeda, Yasuji Arase

  • 1Department of Hepatology, Toranomon Hospital, Tokyo, Japan. k-yusuke@toranomon.gr.jp

The American Journal of Medicine
|December 7, 2007
PubMed

Insights

Hepatitis C virus (HCV) patients who achieve sustained virologic response through interferon therapy show a significantly lower risk of developing malignant lymphoma. Viral elimination protects against lymphomagenesis in HCV-infected individuals.

Area of Science:

  • Hepatology
  • Oncology
  • Virology

Background:

  • Hepatitis C virus (HCV) infection is associated with a higher incidence of malignant lymphoma.
  • Understanding the relationship between HCV, viral elimination, and lymphoma development is crucial for patient management.

Purpose of the Study:

  • To determine the incidence of malignant lymphoma in HCV-infected patients.
  • To investigate the association between malignant lymphoma and viral elimination after interferon therapy.

Main Methods:

  • Retrospective study of 501 HCV patients without interferon therapy and 2708 HCV patients who received interferon therapy.
  • Analysis of cumulative incidence rates of malignant lymphoma development over 15 years.
  • Comparison of lymphoma development rates between patients with sustained virologic response and persistent infection.

Main Results:

  • The annual incidence of malignant lymphoma in HCV patients was found to be 0.23%.
  • Patients achieving sustained virologic response (SVR) after interferon therapy had a 0% cumulative incidence of lymphoma at 15 years.
  • Patients with persistent HCV infection had significantly higher rates of malignant lymphoma development compared to those with SVR (P=.0159).
  • The hazard ratio for lymphomagenesis was significantly lower in patients with SVR (0.13; P=.049).

Conclusions:

  • Sustained virologic response induced by interferon therapy offers protection against the development of malignant lymphoma in patients with chronic HCV.
  • Interferon therapy and achieving viral elimination are key factors in reducing lymphoma risk in HCV-positive individuals.
Abstract

More Related Videos

Expanding Cytotoxic T Lymphocytes from Umbilical Cord Blood that Target Cytomegalovirus, Epstein-Barr Virus, and Adenovirus11:18

Expanding Cytotoxic T Lymphocytes from Umbilical Cord Blood that Target Cytomegalovirus, Epstein-Barr Virus, and Adenovirus

Published on: May 7, 2012

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...